For how long can hepatitis B virus, hepatitis C virus, and HIV remain infectious outside the human body?

Environmental Infectivity Duration: HBV vs HCV vs HIV

• Bold recommendation: Assume hepatitis B virus (HBV) can remain infectious on surfaces for at least 7 days; hepatitis C virus (HCV) for up to 5 days under favorable conditions; and HIV for far shorter periods, with viability rapidly lost and rarely beyond hours to a few days depending on conditions. 1, 2, 3, 4, 5

HBV (Hepatitis B virus)

• Infectious on environmental surfaces for ≥7 days at room temperature; transmission can occur even without visible blood and at low inocula. This is the most stable of the three and the highest transmission risk from environmental contamination. 1, 2, 3
• Pitfalls/caveats:
  • All HBsAg-positive persons are potentially infectious; HBeAg or high HBV DNA increases risk. 1
  • Surfaces contaminated with minute amounts can still transmit. Use standard disinfection and avoid sharing personal items (razors, toothbrushes). 1

HCV (Hepatitis C virus)

• Environmental survival with retained infectivity has been demonstrated up to 5 days on inanimate surfaces in the presence of serum; infectivity after drying at room temperature was shown at least through 16 hours in primate inoculation, but not at 4–7 days in that model. The best single recent, high-quality experimental study supports survival up to 5 days. 5, 6
• Pitfalls/caveats:
  • Survival depends on temperature, humidity, organic load (serum), and volume. Use effective disinfectants (e.g., 1-propanol and standard hospital-grade products) to inactivate. 5

HIV

• Much less stable than HBV and HCV outside the body; viable virus in syringes is uncommon and declines rapidly, with only a small fraction showing viable virus after days at room temperature and even less at higher temperatures. Transmission from community-discarded needles is exceedingly rare. 4
• Practical interpretation: infectivity typically falls within hours; environmental transmission risk is very low outside of blood-filled devices. 4

Actionable infection-control priorities (to reduce morbidity, mortality, QOL impact)

• Treat all blood/body-fluid contamination as potentially infectious; promptly disinfect with EPA-registered hospital disinfectants effective against HBV/HCV. 1
• For community or occupational exposures:
  • Do not test discarded needles; assess exposure risk and follow established PEP/testing algorithms (HBV vaccination/HBIG as indicated; HIV nPEP within 72 hours when criteria met; no HCV PEP—test and monitor). 7, 4
• Common pitfalls to avoid:
  • Underestimating HBV’s 7+ day surface viability. 1
  • Assuming dried blood is safe; HCV can persist days with serum present. 5
  • Overestimating HIV risk from casual surface contact; focus on percutaneous blood exposures. 4